Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000899243-21-042033

Director sold 2,200 shares at $24.78 ($54,511)

From the SEC's structured data for this filing

Trades in this filing

Jovan-Embiricos Morana · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-10-27 Sale : show line 1 in the form −1,870 $24.78 $46,334 1,386,309 I
2021-10-27 Sale : show line 2 in the form −330 $24.78 $8,177 344,642 I
Open-market sales · 2,200 sh · avg $24.78 · $54,511
Loading xslF345X03/doc4.xml…